# MYTELASE
> **NDA010155** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1956-05-01
## Drug
- **FDA Application Number:** NDA010155
- **Application type:** New Drug Application
- **Brand name:** MYTELASE
- **Generic name:** Ambenonium Chloride
- **Active ingredients:** AMBENONIUM CHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANOFI AVENTIS US
- **First approval:** 1956-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010155)
---
*AI Analytics · CC0 1.0*